1. Home
  2. TLSA vs BUJA Comparison

TLSA vs BUJA Comparison

Compare TLSA & BUJA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSA
  • BUJA
  • Stock Information
  • Founded
  • TLSA 2013
  • BUJA 2022
  • Country
  • TLSA United Kingdom
  • BUJA Malaysia
  • Employees
  • TLSA N/A
  • BUJA N/A
  • Industry
  • TLSA Biotechnology: Pharmaceutical Preparations
  • BUJA Blank Checks
  • Sector
  • TLSA Health Care
  • BUJA Finance
  • Exchange
  • TLSA Nasdaq
  • BUJA Nasdaq
  • Market Cap
  • TLSA 87.8M
  • BUJA N/A
  • IPO Year
  • TLSA 2000
  • BUJA 2023
  • Fundamental
  • Price
  • TLSA $1.20
  • BUJA $10.96
  • Analyst Decision
  • TLSA
  • BUJA
  • Analyst Count
  • TLSA 0
  • BUJA 0
  • Target Price
  • TLSA N/A
  • BUJA N/A
  • AVG Volume (30 Days)
  • TLSA 145.8K
  • BUJA 2.7K
  • Earning Date
  • TLSA 05-10-2024
  • BUJA 01-01-0001
  • Dividend Yield
  • TLSA N/A
  • BUJA N/A
  • EPS Growth
  • TLSA N/A
  • BUJA N/A
  • EPS
  • TLSA N/A
  • BUJA 0.29
  • Revenue
  • TLSA N/A
  • BUJA N/A
  • Revenue This Year
  • TLSA N/A
  • BUJA N/A
  • Revenue Next Year
  • TLSA N/A
  • BUJA N/A
  • P/E Ratio
  • TLSA N/A
  • BUJA $37.13
  • Revenue Growth
  • TLSA N/A
  • BUJA N/A
  • 52 Week Low
  • TLSA $0.41
  • BUJA $10.30
  • 52 Week High
  • TLSA $1.74
  • BUJA $12.18
  • Technical
  • Relative Strength Index (RSI)
  • TLSA 65.44
  • BUJA 67.66
  • Support Level
  • TLSA $0.83
  • BUJA $10.85
  • Resistance Level
  • TLSA $0.92
  • BUJA $10.85
  • Average True Range (ATR)
  • TLSA 0.09
  • BUJA 0.00
  • MACD
  • TLSA 0.03
  • BUJA -0.00
  • Stochastic Oscillator
  • TLSA 84.52
  • BUJA 87.50

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

About BUJA Bukit Jalil Global Acquisition 1 Ltd.

Bukit Jalil Global Acquisition 1 Ltd is a blank check company.

Share on Social Networks: